ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979

Varmus Pools $13.4 M. To Fund Projects; NCI Gives $2.6 Mil.

December 9, 1994

No Cancer Letter for Two Weeks

August 13, 1993

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011